logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Breast cover

Breast

IF7.9
Papers7287
Citations8179
Journal Papers 8947
Publication Date
delete
Impact of anti-HER2 therapies on potentially avoidable deaths from stage II and III HER2-positive breast cancer in the Brazilian public healthcare system
deleteBreast
IF7.9
delete2026-10-01
delete0
deleteOAAI
deleteAndré Mattar; Francisco Pimentel Cavalcante; Nelson Francisco Correa-Netto; Iago Silveira; Eduardo Baldassin Pavanel; Cintia S. Kurokawa La Scala; Patricia Klarmann Ziegelmann
deleteShare
deleteSave
Effect of dose-dense adjuvant chemotherapy in patients with node-positive early breast cancer according to estrogen receptor levels: an exploratory analysis of the GIM2 trial
deleteBreast
IF7.9
delete2026-09-29
delete0
deleteOAAI
deleteCarmine De Angelis; Alessandra Rosa; Virginia Delucchi; Francesca Poggio; Mario Giuliano; Michelino De Laurentiis; Anita Rimanti; Anna Turletti; Angela Vaccaro; Alessandra Fabi; Simona Gasparro; Ornella Garrone; Fabio Puglisi; Barbara Cardinali; Piero Fregatti; Matteo Lambertini; Luca Boni; Eva Blondeaux; Lucia Del Mastro
deleteShare
deleteSave
Chemotherapy outcomes in human epidermal growth factor receptor 2-low, hormone receptor-positive metastatic breast cancer: Insights from the French multicenter ESME database
deleteBreast
IF7.9
delete2026-09-27
delete0
deleteOAAI
deleteWilliam Jacot; Pauline Macouillard; Suyuan Zhang; Danalyn Byng; Shannon Hunter; Vincent Massard; Jean-Sébastien Frenel; David Pérol; Etienne Brain; Audrey Mailliez; Thomas Bachelot; Monica Arnedos; Lise Bosquet; Véronique Diéras
deleteShare
deleteSave
Subtype-specific screen-detected and interval breast cancer rates in population screening: a BreastScreen Queensland cohort study
deleteBreast
IF7.9
delete2026-09-26
delete0
deleteOAAI
deleteNaomi Noguchi; Nick Ormiston-Smith; Michael Luke Marinovich; Julie Moore; Nehmat Houssami
deleteShare
deleteSave
Analysis of outcomes of nab-paclitaxel compared to other taxanes in early breast cancer: A study revealing the critical role of calendar-time bias in real-world drug comparisons
deleteBreast
IF7.9
delete2026-09-25
delete0
deleteOAAI
deleteJingjing Xiao; Meiling Huang; Changjiao Yan; Zhe Wang; Ting Wang
deleteShare
deleteSave
Prospective Assessment of Incomplete Ovarian Suppression in Breast Cancer using LC-MS/MS and Immunoassays for Estradiol
deleteBreast
IF7.9
delete2026-09-22
delete0
deleteOAAI
deleteCatherine M. Kelly; Lajos Pusztai; Kathleen Bennett; Siun Walsh; Mohammed Z. Zamer; Emily Harrold; Shahid Iqbhal; Janice M. Walshe; Michaela J. Higgins; Caitriona Cahir; Keith Mulready
deleteShare
deleteSave
Remnant cholesterol inflammatory index for predicting pathological complete response to neoadjuvant therapy in breast cancer: A multicenter external validation study
deleteBreast
IF7.9
delete2026-09-22
delete0
deleteOAAI
deleteGalip Can Uyar; Kadriye Başkurt; Ahmet Oruç; Nargiz Majidova; Orhun Akdoğan; Enes Yeşilbaş; Kadriye Bir Yücel; Melek Karakurt Eryılmaz; Osman Sütcüoğlu; Ömür Berna Çakmak Öksüzoğlu; Mustafa Altınbaş
deleteShare
deleteSave
Surgery-first versus neoadjuvant chemotherapy in stage I (cT1c) triple-negative breast cancer: A critical reappraisal
deleteBreast
IF7.9
delete2026-09-12
delete0
deleteOAAI
deleteM. Dediu; C. Zielinski; V. Preoteasa; A. Bulzan
deleteShare
deleteSave
Prognostic role of thymidine kinase 1 activity in hormone receptor positive metastatic breast cancer. A systematic review and meta-analysis
deleteBreast
IF7.9
delete2026-09-09
delete0
deleteOAAI
deleteIlenia Migliaccio; Roberto Buonaiuto; Giulia Anichini; Chiara Biagioni; Maria Letizia Cataldo; Svitlana Tyekucheva; Mattias Bergqvist; Christos Sotiriou; Laura Biganzoli; Carmine De Angelis; Luca Malorni
deleteShare
deleteSave
Which quality of life issues are important to patients with metastatic breast cancer: Phase 1 and 2 development of European Organisation for Research and Treatment of Cancer metastatic breast cancer module (EORTC QLQ-MBR)
deleteBreast
IF7.9
delete2026-09-05
delete0
deleteOAAI
deleteChristopher Bedding; Kate Absolom; Katarzyna Pogoda; Akihiko Shimomura; Hiroto Ishiki; Juan Ignacio Arraras; Julien Peron; Monica Pinto; Nora Nevries; Omar Shamieh; Tara Chalk; Teresa Young; Vesna Bjelic-Radisic; Waleed Alrjoub; Yuichiro Kikawa; Fatima Cardoso; Galina Velikova
deleteShare
deleteSave
Beyond breast-conservation rates: Measuring eligibility, offer, and choice after neoadjuvant chemotherapy
deleteBreast
IF7.9
delete2026-09-04
delete0
deleteOAAI
deleteChukwumbana Faith Okirie
deleteShare
deleteSave
Clarification of oestrogen receptor thresholds and Allred scoring
deleteBreast
IF7.9
delete2026-09-01
delete0
PREAI
deleteSang, Tony Yiu
deleteShare
deleteSave
Response to correspondence received on New perspectives on endocrine therapy suitability for hormone receptor-positive metastatic breast cancer in clinical practice
deleteBreast
IF7.9
delete2026-09-01
delete0
PREAI
deleteRugo, Hope S.
deleteShare
deleteSave
Cost-effectiveness of abbreviated breast MRI and contrast-enhanced mammography for women with extremely dense breasts in a national breast cancer screening program: a micro-simulation study
deleteBreast
IF7.9
delete2026-08-31
delete0
deleteOAAI
deleteMengmeng Li; Marcel J.W. Greuter; Keris Poelhekken; Monique D. Dorrius; Karin M. Vermeulen; Antoinette D.I. van Asselt; Geertruida H. de Bock
deleteShare
deleteSave
Standardizing imaging-confirmed nodal assessment in early breast cancer: the case for c,iN0
deleteBreast
IF7.9
delete2026-08-27
delete0
deleteOAAI
deleteWiebren A.A. Tjalma
deleteShare
deleteSave
Oncotype DX-guided vs physician-directed chemotherapy and survival in HR+/HER2- breast cancer
deleteBreast
IF7.9
delete2026-08-23
delete0
deleteOAAI
deleteJingkun Li; Xinhao Han; Yan Zhuang; Yinting Liu; Samantha M. Thomas; Jennifer K. Plichta; Jinsong Wang; Bo Lei
deleteShare
deleteSave
Leveraging endocrine sensitivity in ER-positive DCIS: Neoadjuvant therapy and nonoperative management
deleteBreast
IF7.9
delete2026-08-19
delete0
deleteOAAI
deleteRyoko Semba; Sarah Childs; Kate Saw; Davendra Segara; G Bruce Mann; Tadahiko Shien; Stephen Birrell; Yoshiya Horimoto; Goro Kutomi; Elgene Lim
deleteShare
deleteSave
Breast cancer-related fatigue: Mechanisms, biomarkers, risk factors, and intervention strategies
deleteBreast
IF7.9
delete2026-08-18
delete0
deleteOAAI
deleteChaofan Zhao; Qi Qiu; Yuanyuan Wang; Yidi Jiang; Kunshuang Shen; Le Yang; Ye Sun; Zhengcan Zhou; Mingqian Jia; Haibin Liu; Hui Sun; Ning Zhang
deleteShare
deleteSave
Revisiting HER2-negative breast cancer in the era of HER2-low and HER2-ultralow expression: Assessment of interobserver variability
deleteBreast
IF7.9
delete2026-08-18
delete0
deleteOAAI
deleteXiao Huang; Sarah Anderson; Valeria Dal Zotto; Shuko Harada; Andrea G Kahn; Meiling Zhou; Kui Zhang; Kanako Okamoto; Shi Wei
deleteShare
deleteSave
Biomarker-based risk stratification for predicting late recurrence and benefit of extended endocrine therapy: A secondary analysis of the IDEAL trial
deleteBreast
IF7.9
delete2026-08-18
delete0
deleteOAAI
deleteTejal.D. Durgekar; Shyamili Goutham; Xi Zhang; Elma.Meershoek-Klein Kranenbarg; Badada.Ananthamurthy Savitha; Payal Shrivastava; null Deepti; Naveen Krishnamoorthy; Hein Putter; Manvi Sunder; Erik J. Blok; Cornelis.J.H. van de Velde; Peter.J.K. Kuppen; Manjiri Bakre
deleteShare
deleteSave